Science & Enterprise subscription

Follow us on Twitter

  • A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple… https://t.co/0PktfkzyNH
    about 23 mins ago
  • New post on Science and Enterprise: FDA Halts Off-the-Shelf Engineered T-Cell Trial https://t.co/Fbz7IKCgky #Science #Business
    about 27 mins ago
  • If you dig deep into the Science & Enterprise archives, you'll find this site began posting on 6 July 2010, exactly… https://t.co/eGPudMExsK
    about 17 hours ago
  • New post on Science and Enterprise: Essay – Ten Years and Counting https://t.co/bIFz5ld4g4 #Science #Business
    about 17 hours ago
  • A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infectio… https://t.co/auyvJKhyBq
    about 19 hours ago

Please share Science & Enterprise

Glove-App System Translates Sign Language to Speech

Sign language translation glove

University engineers designed a glove with electronic sensors that sends signals to a smartphone app to translate American Sign Language into audible speech. . . . → Read More: Glove-App System Translates Sign Language to Speech

Covid-19 Vaccine for Lower-Income Regions Underway

Robin Shattock

Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries. . . . → Read More: Covid-19 Vaccine for Lower-Income Regions Underway

Industry, Univ. Labs Partner on Covid-19 Therapy

Covid-19 illustration

Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine. . . . → Read More: Industry, Univ. Labs Partner on Covid-19 Therapy

Five Covid-19 Vaccines in Clinical Trials

Coronavirus face mask

A review of vaccines for preventing Covid-19 infections shows five of those projects are in early-stage clinical trials, with 18 more in preclinical stage. . . . → Read More: Five Covid-19 Vaccines in Clinical Trials

Case Study Maps Covid-19 Immune Response

Coronavirus

Infectious disease specialists in Australia tracked the course of an early patient’s immune-system response to non-severe novel coronavirus, or Covid-19, infections. . . . → Read More: Case Study Maps Covid-19 Immune Response

Trial Testing Arthritis Drug as Covid-19 Treatment

Covid-19 illustration

A clinical trial is enrolling patients with severe novel coronavirus infections to test a synthetic antibody now approved to treat rheumatoid arthritis. . . . → Read More: Trial Testing Arthritis Drug as Covid-19 Treatment

Janssen, BARDA Partner on Coronavirus Vaccine

Coronavirus

An industry-government collaboration aims to advance and produce vaccines against the 2019 novel coronavirus outbreak in China and elsewhere. . . . → Read More: Janssen, BARDA Partner on Coronavirus Vaccine

Intl Group Calls for More Coronavirus Vaccines

Hong Kong residents in masks

An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world. . . . → Read More: Intl Group Calls for More Coronavirus Vaccines

Infographic – Countries Where Coronavirus Reported

Research company Statista posted yesterday a map where coronavirus cases are confirmed, and number of cases as of 30 January. But the outbreak is spreading quickly. . . . → Read More: Infographic – Countries Where Coronavirus Reported

Crispr Company Raises $45M in Venture Funds

Editing DNA

A spin-off enterprise from a pioneering Crispr research lab is raising $45 million in venture funds to develop diagnostics and other applications. . . . → Read More: Crispr Company Raises $45M in Venture Funds